Skip to search formSkip to main contentSkip to account menu

MEDI507

Known as: MEDI-507 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Siplizumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Methodes de prevention ou de traitement de malignites cellulaires par administration d'antagonistes de cd2
L'invention concerne l'utilisation d'un antagoniste de CD2, de preference MEDI-507, d'un analogue, d'un derive ou d'un fragment a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)